MediWound Ltd. held an extraordinary general meeting of shareholders on February 19, 2026. Shareholders approved an increase of 300,000 in the number of ordinary shares reserved for issuance under the 2024 Share Incentive Plan.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. MediWound Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001178913-26-000576), on February 19, 2026, and is solely responsible for the information contained therein.